Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics, Pharmacodynamics,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02752087
What this trial is testing

Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 24
Early research (Phase 1)Study completedNCT03490786
What this trial is testing

A Dose Escalating Study to Assess the Safety and Tolerability of GT-001

Who this might be right for
Feeding and Eating Disorders
Gila Therapeutics, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT02254707
What this trial is testing

Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 96
Early research (Phase 1)Study completedNCT02392611
What this trial is testing

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer

Who this might be right for
Solid Tumors and Lymphomas
Gilead Sciences 33
Early research (Phase 1)Looking for participantsNCT06801236
What this trial is testing

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)mCRPC (Metastatic Castration-resistant Prostate Cancer)
Acerand Therapeutics (Hong Kong) Limited 88
Early research (Phase 1)Study completedNCT00441987
What this trial is testing

Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer 96
Early research (Phase 1)Study completedNCT02156544
What this trial is testing

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Who this might be right for
Dyslipidemia
Chong Kun Dang Pharmaceutical 41
Early research (Phase 1)Study completedNCT03932864
What this trial is testing

Study Assessing Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MGTA-145 in Healthy Volunteers as a Single Agent or in Combination With Plerixafor

Who this might be right for
Healthy Volunteers
Ensoma 107
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05504187
What this trial is testing

Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Kira Pharmacenticals (US), LLC. 24
Early research (Phase 1)Study completedNCT04448821
What this trial is testing

A Clinical Trial to Evaluate the Effect of Nilotinib on the PK/PD of Meformin

Who this might be right for
Healthy
Hyewon Chung 16
Testing effectiveness (Phase 2)Study completedNCT06560684
What this trial is testing

CROSSOVER STUDY OF ON-DEMAND PREP FORMULATIONS COMPARING RECTAL AND ORAL TENOFOVIR

Who this might be right for
Tenofovir
National Institute of Allergy and Infectious Diseases (NIAID) 150
Early research (Phase 1)Study completedNCT05769595
What this trial is testing

Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012)

Who this might be right for
End-Stage Renal Disease (ESRD)End-Stage Kidney Disease (ESKD)Kidney Failure, Chronic
Merck Sharp & Dohme LLC 17
Early research (Phase 1)Looking for participantsNCT07229911
What this trial is testing

TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)

Who this might be right for
Healthy VolunteersPrimary Sclerosing Cholangitis
Takeda 134
Early research (Phase 1)Not Yet RecruitingNCT07617194
What this trial is testing

Study of AHB-171 in Chronic Hepatitis B Participants

Who this might be right for
Hepatitis B, Chronic
AusperBio Therapeutics Inc. 144
Post-approval studies (Phase 4)WithdrawnNCT00362245
What this trial is testing

Amikacin Penetration Into the Cerebrospinal Fluid

Who this might be right for
Gram Negative MeningitisPost Traumatic Bacterial Meningitis
Rambam Health Care Campus
Early research (Phase 1)Ended earlyNCT05038800
What this trial is testing

Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002)

Who this might be right for
Relapsed or Refractory Acute Myeloid LeukemiaRelapsed or Refractory Chronic Myelomonocytic Leukemia
Merck Sharp & Dohme LLC 13
Testing effectiveness (Phase 2)Study completedNCT07814651
What this trial is testing

A Clinical Trial to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Octreotide Long-acting Injection in Patients With Acromegaly

Who this might be right for
Acromegaly
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 78
Early research (Phase 1)Study completedNCT00207051
What this trial is testing

BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies

Who this might be right for
Colorectal Cancer
Bristol-Myers Squibb 62
Testing effectiveness (Phase 2)Looking for participantsNCT06795412
What this trial is testing

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Pyxis Oncology, Inc 220
Early research (Phase 1)Study completedNCT01179581
What this trial is testing

First-in-Human Single Ascending and Multiple Dose of GLPG0634

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 48
Next Page